Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 40% ± 21% | |
lung | 14 studies | 24% ± 10% | |
peripheral blood | 12 studies | 21% ± 6% | |
eye | 7 studies | 29% ± 12% | |
heart | 5 studies | 26% ± 5% | |
liver | 5 studies | 32% ± 14% | |
bone marrow | 4 studies | 20% ± 7% | |
kidney | 4 studies | 19% ± 2% | |
adipose | 4 studies | 39% ± 22% | |
intestine | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 7923.95 | 21 / 21 | 100% | 61.79 | 504 / 504 |
breast | 100% | 7750.62 | 459 / 459 | 100% | 76.67 | 1118 / 1118 |
esophagus | 100% | 7333.47 | 1445 / 1445 | 100% | 64.32 | 183 / 183 |
liver | 100% | 7075.32 | 226 / 226 | 100% | 47.27 | 406 / 406 |
ovary | 100% | 7824.68 | 180 / 180 | 100% | 43.30 | 430 / 430 |
prostate | 100% | 8667.94 | 245 / 245 | 100% | 73.27 | 502 / 502 |
stomach | 100% | 5961.34 | 359 / 359 | 100% | 47.60 | 286 / 286 |
thymus | 100% | 7607.14 | 653 / 653 | 100% | 50.68 | 605 / 605 |
uterus | 100% | 7855.74 | 170 / 170 | 100% | 73.67 | 459 / 459 |
lung | 100% | 8724.43 | 577 / 578 | 100% | 63.47 | 1155 / 1155 |
intestine | 100% | 7831.21 | 966 / 966 | 100% | 49.64 | 526 / 527 |
skin | 100% | 12168.15 | 1808 / 1809 | 100% | 67.06 | 471 / 472 |
kidney | 100% | 6514.11 | 89 / 89 | 99% | 44.81 | 896 / 901 |
brain | 99% | 6170.94 | 2619 / 2642 | 100% | 53.79 | 705 / 705 |
pancreas | 99% | 5051.99 | 325 / 328 | 100% | 50.14 | 178 / 178 |
adrenal gland | 100% | 8503.38 | 258 / 258 | 98% | 42.06 | 226 / 230 |
adipose | 100% | 8129.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 63.21 | 29 / 29 |
muscle | 100% | 28201.79 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 11136.00 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 74.09 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.90 | 1 / 1 |
blood vessel | 100% | 7249.87 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 13848.50 | 925 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 39.06 | 77 / 80 |
heart | 96% | 7276.11 | 826 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031643 | Biological process | positive regulation of myelination |
GO_0050772 | Biological process | positive regulation of axonogenesis |
GO_0051044 | Biological process | positive regulation of membrane protein ectodomain proteolysis |
GO_0006508 | Biological process | proteolysis |
GO_0052548 | Biological process | regulation of endopeptidase activity |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0005739 | Cellular component | mitochondrion |
GO_0030425 | Cellular component | dendrite |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0048408 | Molecular function | epidermal growth factor binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | NRDC |
Protein name | Nardilysin convertase Nardilysin (N-arginine dibasic convertase), isoform CRA_e (Nardilysin convertase) Nardilysin Nardilysin isoform Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase) |
Synonyms | NRD1 hCG_40292 |
Description | FUNCTION: Cleaves peptide substrates on the N-terminus of arginine residues in dibasic pairs. Is a critical activator of BACE1- and ADAM17-mediated pro-neuregulin ectodomain shedding, involved in the positive regulation of axonal maturation and myelination. Required for proper functioning of 2-oxoglutarate dehydrogenase (OGDH) (By similarity). . |
Accessions | ENST00000354831.11 [O43847-2] G3V1R5 Q96L67 ENST00000440943.5 ENST00000352171.12 [O43847-1] O43847 Q6UUU9 ENST00000539524.5 H0Y5G9 |